Galapagos NV
GLPG
#5063
Rank
S$2.40 B
Marketcap
S$35.80
Share price
0.00%
Change (1 day)
-9.11%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of March 2026 : S$5.03 Billion

According to Galapagos NV's latest financial reports the company's total assets are S$5.03 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2026)

Total assets by year

Year Total assets Change
2024-12-31S$5.84 B-8.05%
2023-12-31S$6.36 B-6.56%
2022-12-31S$6.80 B-14.37%
2021-12-31S$7.95 B-14.54%
2020-12-31S$9.30 B1.51%
2019-12-31S$9.16 B307.39%
2018-12-31S$2.24 B8.99%
2017-12-31S$2.06 B25.16%
2016-12-31S$1.64 B140.97%
2015-12-31S$0.68 B57.46%
2014-12-31S$0.43 B-13.56%
2013-12-31S$0.50 B32.09%
2012-12-31S$0.38 B40.54%
2011-12-31S$0.27 B-18.49%
2010-12-31S$0.33 B14.97%
2009-12-31S$0.28 B21.67%
2008-12-31S$0.23 B-23.98%
2007-12-31S$0.31 B-7.88%
2006-12-31S$0.33 B110.85%
2005-12-31S$0.16 B365.6%
2004-12-31S$34.55 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
S$259.39 B 5,046.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$142.58 B 2,729.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$176.20 B 3,396.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$191.32 B 3,696.20%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$166.15 B 3,196.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$147.21 B 2,820.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$107.50 B 2,033.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
S$0.23 B-95.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$51.69 B 925.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel